Table 1. Patient characteristics.
ECOG: Eastern Cooperative Oncology Group.
| Patient, n | 10 |
| Median Age, y (range) | 50 (32-63) |
| BMI (range) | 21.7 (17.8-27.7) |
| ECG Performance Status | |
| 0 | 10 |
| 1 | 0 |
| Treatment, n | |
| Neo-Adjuvant | 7 |
| Adjuvant | 3 |
| Primary Tumor Subtypes, n | |
| Luminal | 4 |
| Luminal HER2 | 3 |
| HER2 | 1 |
| Triple-Negative | 2 |
| Taxane Type, n | |
| Paclitaxel | 2 |
| Docetaxel | 8 |
| Combination Therapy with Trastuzumab and Pertuzumab | 4 |
| Combination Therapy with Calboplatin | 2 |
| Average Cumulative Taxane Dose, mg/m2 | |
| Paclitaxel | 960 |
| Docetaxel | 337.5 |
| Size of SG, n | |
| 5.5 | 7 |
| 6.0 | 3 |
| Size of Compression Socks, n | |
| S | 1 |
| M | 9 |